![Dr. Cyrus Parse Zabetian MD, Neurologist](/fatd/images/avatar.png)
Dr. Cyrus Parse Zabetian MD
Neurologist | Neurology
1660 S Columbian Way Grecc (s-182), Va Pu Seattle WA, 98108About
Dr. Cyrus Zabetian is a distinguished Neurologist in Seattle, WA. Dr. Zabetian specializes in diagnosing, treating, and managing disorders of the brain and nervous system. With expertise in handling complex conditions like epilepsy, multiple sclerosis, and migraines, Dr. Zabetian employs advanced techniques and personalized treatment plans to improve patient outcomes. As a neurologist, Dr. Zabetian is committed to staying abreast of the latest developments in neurological research and therapies.
Education and Training
University of Miami Leonard M. Miller School of Medicine 1994
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Variations in the dopamine beta-hydroxylase gene are not associated with the autonomic disorders, pure autonomic failure, or multiple system atrophy.
- Sigma receptors are associated with cortical limbic areas in the primate brain.
- Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.
- Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.
- Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease.
- Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.
- Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.
- DBH -1021C-->T does not modify risk or age at onset in Parkinson's disease.
- Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.
- Exploring gene-environment interactions in Parkinson's disease.
- Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.
- Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.
- Genetic association between alpha-synuclein and idiopathic Parkinson's disease.
- Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism.
- LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay.
Clinical Trials
Dr. Cyrus Parse Zabetian MD's Practice location
Dr. Cyrus Zabetian, MD
1660 S Columbian Way Grecc (s-182), Va Pu -Seattle, WA 98108Get Direction
Dr. Cyrus Parse Zabetian MD's reviews
Write ReviewPatient Experience with Dr. Zabetian
Recommended Articles
- This Is How Parkinson's Affects Life Expectancy
When anyone talks about any chronic disease like Parkinson’s, perhaps the most important question that comes to mind is how does it affect life expectancy? However, living for a long time is not the only important thing.Another critical question is, what are the problems that affect the quality of...
- Anti-Inflammatory Drugs for Multiple Sclerosis
Multiple sclerosis is a disease that affects the brain and spinal cord. It involves an immune-mediated process, which results in an abnormal response. Such abnormal response leads to the damage of the central nervous system tissue and the immune system, which attacks the myelin causing...
- Literally Fighting Parkinson's: Fitness Program Focuses on Boxing to Alleviate Symptoms
“Exercise is good for the brain” is a statement largely supported by scientists, physicians, researchers and all kinds of experts in the field of neurology. Some of the benefits the brain can receive from regular exercise are:...
- What Are the Symptoms of a Concussion?
A concussion refers to a traumatic brain injury that is not very serious. The word has its origin from concutere, the Latin word for ‘violent shaking’. Concussions commonly occur during contact sports, recreation activities, accidents, injuries, and falls. Concussions are very common among...
- Hospital Outcomes Proven to Be Worse for Dementia Patients
Patients with delirium or dementia have inferior treatment during hospital stays, a large population study from the University of Stirling shows. Professor Emma Reynish, the study’s author and lead researcher, uncovered markedly different results in outcomes.“People who are admitted to hospital...
- Sniff Tests May Provide Early Testing for Alzheimer’s
Alzheimer’s disease is a neurodegenerative disease which can start a decade before symptoms allow for an easy diagnosis. While genetic factors and other risks can be examined to determine whether or not an individual is at high risk of developing Alzheimer’s, so far there is no good way to...
Nearby Providers
- Mrs. Sujata C. Poisson M.D.34617 11 Place South Federal Way WA 98003
- Dr. Allen Scott Nielsen MD1100 9th Ave Seattle WA 98101
- Dr. Natalia Murinova M.D.1959 NE Pacific St Seattle WA 98195
- John W Miller OtherHarborview Medical Center Seattle WA 98104
- Dr. William E Berg M.D.515 Minor Ave Seattle WA 98104
- Dr. Fatima Milfred M.D.925 SENECA ST SEATTLE WA 98101
Nearest Hospitals
SWEDISH MEDICAL CENTER / CHERRY HILLl
500 17TH AVENUE SEATTLE WA 98122SWEDISH MEDICAL CENTERl
747 BROADWAY SEATTLE WA 98122HARBORVIEW MEDICAL CENTERl
325 9TH AVENUE SEATTLE WA 98104